Andersen, Mads Albrecht http://orcid.org/0000-0001-6231-5823
Buron, Mathias Due http://orcid.org/0000-0003-1260-1156
Magyari, Melinda http://orcid.org/0000-0002-0972-5222
Funding for this research was provided by:
Lundbeckfonden
Article History
Received: 18 November 2020
Revised: 20 February 2021
Accepted: 22 February 2021
First Online: 7 March 2021
Declarations
:
: Mads Albrecht Andersen reports no disclosures. Dr. Buron has received support for congress participation from Roche. Dr. Magyari has served on scientific advisory board for Biogen, Sanofi, Roche, Novartis, Merck and AbbVie, has received honoraria for lecturing from Biogen, Merck, Novartis, Sanofi, Genzyme, has received research support and support for congress participation from Biogen, Genzyme, Teva, Roche, Merck and Novartis.
: This study was approved by the Danish Data Protection Agency (approval number P-2019-734). Ethics approval is not required in Denmark for non-interventional studies.